Showing results (41-50 of 59) with videos related to
Sort By:
Pageof 6
Cancer Chemotherapy and Pharmacology|January 1, 1997
Phase II trial of chloroquinoxaline sulfonamide (CQS) in patients with stage III and IV non-small-cell lung cancerV A Miller, J R Rigas, W P Tong, et al.Radiology|March 1, 1989
Superior sulcus tumors: CT and MR imagingR T Heelan, B E Demas, J F Caravelli, et al.American Journal of Clinical Oncology|October 1, 1985
Phase II trial of oral 4-demethoxydaunorubicin in patients with non-small cell lung cancerM G Kris, R J Gralla, D P Kelsen, et al.Chest|March 1, 1985
Trial of vindesine plus mitomycin in stage-3 non-small cell lung cancer. An active regimen for outpatient treatmentM G Kris, R J Gralla, D P Kelsen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1986
Frequency and prognostic importance of pretreatment clinical characteristics in patients with advanced non-small-cell lung cancer treated with combination chemotherapyJ P O'Connell, M G Kris, R J Gralla, et al.Cancer|February 15, 1995
Phase II trial of a 75-mg/m2 dose of docetaxel with prednisone premedication for patients with advanced non-small cell lung cancerV A Miller, J R Rigas, P A Francis, et al.Lung Cancer (Amsterdam, Netherlands)|April 1, 1995
Effectiveness and toxicity of preoperative therapy in stage IIIA non-small cell lung cancer including the Memorial Sloan-Kettering experience with induction MVP in patients with bulky mediastinal lymph node metastases (Clinical N2)M G Kris, K M Pisters, R J Ginsberg, et al.Cancer|March 15, 1983
Cisplatin, vindesine and bleomycin (CVB) combination chemotherapy of advanced non-small cell lung cancerL M Itri, R J Gralla, D P Kelsen, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 1999
Phase I study of the sequential administration of edatrexate and paclitaxel in patients with advanced solid tumorsJ R Rigas, M G Kris, V A Miller, et al.Cancer Treatment Reports|September 1, 1986
Trial of the combination of mitomycin, vindesine, and cisplatin in patients with advanced non-small cell lung cancerM G Kris, R J Gralla, M S Wertheim, et al.Pageof 6